INIP

Across TCGA pan-cancer cohorts, INIP Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated INIP data layer compared with 25 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher INIP Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated INIP expression acts as an unfavorable survival marker.

BLCA, HNSC, and LIHC are the cancer types where INIP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.509	0.720	<.001	40	view →
HNSC	OS	Median	All	0.174	0.751	.001	33	view →
LIHC	OS	Median	All	0.083	0.783	<.001	12	view →
SKCM	DFS	Median	All	0.100	0.728	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

INIP–BLCA (OS)

Open the BLCA breakdown →